See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645569_2023_DICE_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001645569')"} |
Graph
Absolute values for 0001645569, DICE Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 577,762,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,921,000 |
| 3 | remainder_Assets | 13,295,000 |
| 4 | LiabilitiesCurrent | 15,149,000 |
| 5 | LiabilitiesNoncurrent | 11,841,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,662,000 |
| 9 | ResearchAndDevelopmentExpense | 62,559,000 |
| 10 | remainder_Expenses | 679,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,013,000 |
| 13 | remainder_ComprehensiveNetIncome | -539,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 593,978,000 |
| 1 | Liabilities | 26,990,000 |
| 2 | Expenses | 88,900,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 566,988,000 |
| 5 | NetIncome | -83,887,000 |
| 6 | ComprehensiveNetIncome | -84,156,500 |
| 7 | BaseVar | 357,710,000 |
| 8 | EconomicCapitalRatio | 2.87 |